Press Releases

The TIC market for the pharmaceuticals & biotech industry is expected to witness a CAGR of 5.6% during the forecast period. TIC services offers standards in the manufacturing process by conducting tests, validating, inspections, auditing, and certifications in accordance with regulations globally. TIC is playing an important role in the healthcare sector so as to meet the safety and health requirements of the consumers. The healthcare division such as pharmaceutical, diagnostics, medical devices, clinical research, and digital health applications has witnessed substantial demand in TIC practices owing to the increasing need to acquire healthcare services and related products, including medicinal supplies. Moreover, pharmaceutical companies are innovating new drugs, antidotes, and vaccines to curb the spread of coronavirus. The industry players are focus on establishing new test services to understand the seriousness of COVID-19 infection and treat patients.

The TIC (Testing, Inspection, and Certification) market for the pharmaceutical and biotech industry refers to the industry involved in providing testing, inspection, and certification services specifically tailored for pharmaceutical and biotechnology products, processes, and facilities. These services ensure compliance with regulatory standards, quality control, safety, and efficacy of pharmaceutical and biotech products throughout their lifecycle.

The TIC services provided to the pharmaceutical and biotech industry encompass a wide range of activities, including:

Testing Services: TIC companies offer comprehensive testing services to assess the quality, safety, and efficacy of pharmaceutical and biotech products. This includes chemical and microbiological testing, stability testing, purity testing, potency testing, and analysis of raw materials, intermediates, and finished products.

Inspection Services: TIC companies conduct inspections of pharmaceutical manufacturing facilities, laboratories, and distribution centers to ensure compliance with regulatory standards, Good Manufacturing Practices (GMP), and Good Laboratory Practices (GLP). Inspections help identify potential risks, deviations, and non-compliance issues that need to be addressed.

Certification Services: TIC companies provide certification services that verify compliance with international standards and regulations, such as ISO standards, GMP, GLP, and Good Distribution Practices (GDP). Certification assures that pharmaceutical and biotech companies adhere to industry best practices and meet quality and safety requirements.

Regulatory Compliance Support: TIC companies offer expertise and assistance in navigating complex regulatory frameworks and ensuring compliance with regulations and guidelines set by regulatory authorities such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regional health authorities. This includes guidance on regulatory submissions, documentation, and compliance audits.

Validation Services: TIC companies perform validation studies to ensure that processes, equipment, and systems used in the pharmaceutical and biotech industry are qualified, validated, and operate within specified parameters. This includes validation of manufacturing processes, equipment qualification, cleaning validation, and computerized systems validation.

The COVID-19 pandemic has led to disruptions in the supply chain but acts as a catalyst to bring changes in the healthcare sector, resulting in providing the trend of digitalization. TIC service providers are concentrating on developing and innovating services and delivery models which can identify the latent demand for rising automation, remotely-performed services, and enhanced digitization during the COVID-19 outbreak.  

Element Materials Technology (Element) has acquired Arch Sciences Group (Arch), a leading provider of analytical services and laboratory solutions to customers in the pharmaceuticals sector. As well as marking Element’s entry into the European pharmaceutical market, the move means that the life sciences end market is now the largest within Element.

Browse 53 market data Tables and 35 Figures spread through 250 Pages and in-depth TOC on " TIC Market for Pharmaceuticals & Biotech Industry by Sourcing Type (In-House and Outsourced), by Service Type (Testing, Inspection, and Certification), by Industry Vertical (Extractable and Leachable Studies, Environmental Monitoring, Biopharmaceutical and Biologics Analysis, Sterile Compounding, Pharmaceutical Method Development and Research, Pharmaceutical X-Ray Diffraction, Excipient Raw Materials and Container Testing, Material Sciences Testing, Disinfection Qualification, Trace Metal Services, and Others), and Region - Global Forecast to 2030"

By service type, testing dominates the TIC market for the pharmaceuticals & biotech industry during the forecast period.

Based on service type, the TIC market for the pharmaceuticals and biotech industry is segmented into testing, inspection, and certification. Testing dominates the market owing to innovation and globalization which are creating opportunities for new drugs, biologics, nutraceuticals. Pharmaceutical laboratories offer specialized testing services and include environmental monitor, formulation development, sterility, elemental impurity testing on products.

Global TIC Market for Pharmaceuticals & Biotech Industry Segmentation Analysis

Discover More About This Report, Download A Free Sample Copy of TIC Market for Pharmaceuticals & Biotech Industry

“North-America dominates the TIC market for pharmaceuticals & biotech industry.”

North America is anticipated to dominate the market during the forecast period 2023-2030 owing to the easy availability of TIC services, the existence of TIC payers, high adoption of TIC services in the healthcare industry.

Some of the key players operating in the TIC market in the pharmaceuticals & biotech industry: Intertek Group plc, Bureau Veritas, UL LLC, SGS SA, Eurofins Scientific, The British Standards Institution, ALS Limited, DEKRA SE, Applus+, and TUV SUD.

Scope of the Report

Global TIC Market for Pharmaceuticals & Biotech Industry- Market Coverage

Sourcing Type Insight and Forecast 2018-2030

• In-House
• Outsourced

Service Type Insight and Forecast 2018-2030

• Testing
• Inspection
• Certification

Industry Vertical Insight and Forecast 2018-2030

• Extractable and Leachable Studies
• Environmental Monitoring
• Biopharmaceutical and Biologics Analysis
• Sterile Compounding
• Pharmaceutical Method Development and Research
• Pharmaceutical X-Ray Diffraction
• Excipient Raw Materials and Container Testing
• Material Sciences Testing
• Disinfection Qualification
• Trace Metal Services
• Others

Geographical Segmentation

TIC Market for Pharmaceuticals & Biotech Industry by Region

North America

• By Sourcing Type
• By Service Type
• By Industry Vertical
• By Country – U.S., Canada, and Mexico

Europe

• By Sourcing Type
• By Service Type
• By Industry Vertical
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Sourcing Type
• By Service Type
• By Industry Vertical
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Sourcing Type
• By Service Type
• By Industry Vertical
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries